Alzheimer's Disease Is a Multi-Organ Disorder: It May Already Be Preventable

被引:6
|
作者
Eiser, Arnold R. [1 ,2 ]
Fulop, Tamas [3 ]
机构
[1] Univ Penn, Penn Ctr Publ Hlth, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Excellence Environm Toxicol, Environm Neurosci Grp, Philadelphia, PA 19104 USA
[3] Univ Sherbrooke, Ctr Aging, Sherbrooke, PQ, Canada
关键词
Alzheimer's disease; biotoxins; dementia; dysbiosis; environmental exposure; metabolism; neuroinflammation;
D O I
10.3233/JAD-221078
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In this commentary, we offer an overview of the several environmental and metabolic factors that have been identified as contributing to the development of Alzheimer's disease (AD). Many of these factors involve extracranial organ systems including immune system dysfunction accompanied by neuroinflammation (inflammaging), gastrointestinal dysbiosis, insulin resistance, and hepatic dysfunction. A variety of microbial factors including mouth flora, viruses, and fungi appear to play a significant role. There is a role for the colonic microbiome becoming dysbiotic and producing toxic metabolites. Declining hepatic function contributes diminished neuronal precursors and reduces toxin elimination. Environmental toxins especially metals play an important role in impairing the blood-brain barrier and acting synergistically with biotoxins and other toxic chemicals. Prevention and treatment of AD appears to require measuring several of these biomarkers and implementing corrective actions regarding such toxicants and correcting metabolic dysfunction at early or preclinical stages of this disorder.
引用
收藏
页码:1277 / 1281
页数:5
相关论文
共 50 条
  • [21] Multi-organ vaso-occlusive disease: Buerger's or Kohlmeier-Degos disease?
    Choo, Shi Z.
    Simpson, Ian
    Finlay, Moira J.
    Mulley, William R.
    PATHOLOGY, 2017, 49 (07) : 798 - 801
  • [22] TBCK syndrome: a rare multi-organ neurodegenerative disease
    Durham, Emily L.
    Angireddy, Rajesh
    Black, Aaron
    Melendez-Perez, Ashley
    Smith, Sarina
    Gonzalez, Elizabeth M.
    Navarro, Kristen G.
    Diaz, Abdias
    Bhoj, Elizabeth J. K.
    Katsura, Kaitlin A.
    TRENDS IN MOLECULAR MEDICINE, 2023, 29 (10) : 783 - 785
  • [23] Renewing our understanding of tuberculosis as a multi-organ disease
    Kuze, F
    INTERNAL MEDICINE, 1996, 35 (11) : 839 - 840
  • [24] A new disorder of praxis in neurodegenerative disease that may be part of Alzheimer's disease
    Kawai, Y.
    Midorikawa, A.
    Sugimoto, A.
    Futamura, A.
    Sobue, G.
    Kawamura, M.
    NEUROCASE, 2013, 19 (04) : 408 - 415
  • [25] Fabry Disease: From Dermatologic Entity to a Treatable Multi-Organ Disease
    Desnick, R. J.
    CLINICAL THERAPEUTICS, 2010, 32 : S90 - S92
  • [26] Multi-Organ Fibrosis: When Pulmonary Fibrosis Is Not A Single-Organ Disease
    Silhan, L. L.
    Garibaldi, B. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Multi-organ denervation: a novel approach to combat cardiometabolic disease
    Márcio Galindo Kiuchi
    Revathy Carnagarin
    Vance B. Matthews
    Markus P. Schlaich
    Hypertension Research, 2023, 46 : 1747 - 1758
  • [28] Rituximab may allow to improve multi-organ involvement in patients with cGVHD.
    Zaja, FF
    Bacigalupo, A
    Bosi, AAB
    Scimè, RR
    Milone, GG
    Falda, MM
    Vener, C
    Laszlo, D
    Alessandrino, EP
    Narni, F
    Sica, S
    Olivieri, A
    Sperotto, AA
    Fanin, RR
    BLOOD, 2005, 106 (11) : 867A - 867A
  • [29] Multi-organ denervation: a novel approach to combat cardiometabolic disease
    Kiuchi, Marcio Galindo
    Carnagarin, Revathy
    Matthews, Vance B.
    Schlaich, Markus P.
    HYPERTENSION RESEARCH, 2023, 46 (07) : 1747 - 1758
  • [30] Multi-organ ultrasound for SARS-COV-2 disease
    Hernandez Piriz, Alba
    Jimenez Virumbrales, David
    Barba Martin, Raquel
    Canora Lebrato, Jesus
    Zapatero Gaviria, Antonio
    De Casasola Sanchez, Gonzalo Garcia
    GALICIA CLINICA, 2022, 83 (04): : 10 - 16